Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Ocugen Inc (NASDAQ: OCGN) closed at $1.44 up 2.86% from its previous closing price of $1.4. In other words, the price has increased by $2.86 from its previous closing price. On the day, 1.34 million shares were traded. OCGN stock price reached its highest trading level at $1.465 during the session, while it also had its lowest trading level at $1.41.
Ratios:
For a deeper understanding of Ocugen Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.85 and its Current Ratio is at 1.85. In the meantime, Its Debt-to-Equity ratio is 9.34 whereas as Long-Term Debt/Eq ratio is at 9.10.
Upgrades & Downgrades
In the most recent recommendation for this company, Maxim Group on October 15, 2024, initiated with a Buy rating and assigned the stock a target price of $4.
On March 01, 2023, Chardan Capital Markets Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $3.50.
On August 23, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.Mizuho initiated its Buy rating on August 23, 2022, with a $5 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 09 ’25 when MARNA C. WHITTINGTON bought 112,205 shares for $1.10 per share.
PRABHAVATHI FERNANDES bought 146,705 shares of OCGN for $171,029 on Jun 11 ’25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OCGN now has a Market Capitalization of 449740992 and an Enterprise Value of 450139968. For the stock, the TTM Price-to-Sale (P/S) ratio is 83.75 while its Price-to-Book (P/B) ratio in mrq is 127.32. Its current Enterprise Value per Revenue stands at 83.825 whereas that against EBITDA is -7.828.
Stock Price History:
The Beta on a monthly basis for OCGN is 3.51, which has changed by 0.7021277 over the last 52 weeks, in comparison to a change of 0.16098404 over the same period for the S&P500. Over the past 52 weeks, OCGN has reached a high of $1.90, while it has fallen to a 52-week low of $0.51. The 50-Day Moving Average of the stock is 5.65%, while the 200-Day Moving Average is calculated to be 32.94%.
Shares Statistics:
For the past three months, OCGN has traded an average of 4.70M shares per day and 4438260 over the past ten days. A total of 312.32M shares are outstanding, with a floating share count of 307.65M. Insiders hold about 1.49% of the company’s shares, while institutions hold 21.03% stake in the company. Shares short for OCGN as of 1765756800 were 58994853 with a Short Ratio of 12.54, compared to 1763078400 on 59091529. Therefore, it implies a Short% of Shares Outstanding of 58994853 and a Short% of Float of 19.18.
Earnings Estimates
The dynamic stock of Ocugen Inc (OCGN) is currently being evaluated by a team of 4.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.05 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.22 and -$0.23 for the fiscal current year, implying an average EPS of -$0.23. EPS for the following year is -$0.24, with 4.0 analysts recommending between -$0.17 and -$0.29.
Revenue Estimates
A total of 5 analysts have provided revenue estimates for OCGN’s current fiscal year. The highest revenue estimate was $6.1M, while the lowest revenue estimate was $4.61M, resulting in an average revenue estimate of $5.4M. In the same quarter a year ago, actual revenue was $4.05M
